Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments related to the settlement of the contingent consideration liability, Financing activities				$ 32,798	$ 489
Payments related to the settlement of the contingent consideration liability, Operating activities				1,800
Impairment of intangible assets	$ 0			1,700	1,600
Loss on disposition of business				1,254
Impairment loss on operating lease asset	0	$ 1,400		0
Allowance for expected credit losses	192	1,107	$ 932	192	1,107	$ 199	$ 199	$ 730
Fibrovein Holdings Limited | Disposal Group, Not Discontinued Operations [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on disposition of business	1,300
Cash	1,000			1,000
Inventory	1,200			1,200
Reclassification of foreign currency translation gains	1,000
STD Pharmaceutical Products Limited
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of intangible assets				1,700
Selio
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term notes receivable	2,400			2,400			2,300
Allowance for expected credit losses	200			200			200
ArraVasc Limited
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of intangible assets		1,600
Impairment of property and equipment		$ 1,300			$ 1,300
Director | Cianna Medical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent payments related to acquisition			$ 0	1,600
Other long-term obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, noncurrent	5,700			5,700			13,500
Accrued expenses
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, current	$ 11,700			$ 11,700			$ 34,700